SEC 13F Intelligence

Elk Creek Partners, LLC / LGND

Elk Creek Partners, LLC’s Ligand Pharmaceuticals Inc Position

Does Elk Creek Partners, LLC own Ligand Pharmaceuticals Inc (LGND)? Yes — 246.3K shares worth $18M (+3.08% of its 13F portfolio) as of Q1 2020, up from 236.9K shares the prior filed quarter.

Position Value
$18M
Q1 2020
Shares
246.3K
% of Portfolio
+3.08%
Quarters Held
6
currently held

Position History LGND

Reported value by quarter
Q4 ’18: $12MQ4 ’18Q1 ’19: $26MQ1 ’19Q2 ’19: $28MQ2 ’19Q3 ’19: $34MQ3 ’19Q4 ’19: $25MQ4 ’19Q1 ’20: $18MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020246.3K$18M+3.08%
Q4 2019236.9K$25M+2.84%
Q3 2019341.6K$34M+2.92%
Q2 2019241.1K$28M+2.06%
Q1 2019209.8K$26M+1.90%
Q4 201892.0K$12M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Elk Creek Partners, LLC’s full portfolio or all institutional holders of LGND.